Alzinova AB (publ) (ALZ.ST)

SEK 1.9

(-1.55%)

Eps Summary of Alzinova AB (publ)

  • Alzinova AB (publ)'s latest annual eps in 2023 was -0.41 SEK , up 24.07% from previous year.
  • Alzinova AB (publ)'s latest quarterly eps in 2024 Q2 was -0.11 SEK , down 0.0% from previous quarter.
  • Alzinova AB (publ) reported an annual eps of -0.54 SEK in 2022, down -25.58% from previous year.
  • Alzinova AB (publ) reported an annual eps of -0.43 SEK in 2021, down -16.22% from previous year.
  • Alzinova AB (publ) reported a quarterly eps of -0.11 SEK for 2024 Q2, down 0.0% from previous quarter.
  • Alzinova AB (publ) reported a quarterly eps of -0.10 SEK for 2023 Q2, up 25.23% from previous quarter.

Annual Eps Chart of Alzinova AB (publ) (2023 - 2012)

Created with Highcharts 11.1.0YearsEPS201220132014201520162017201820192020202120222023-1.5 SEK-1.25 SEK-1 SEK-0.75 SEK-0.5 SEK-0.25 SEK0 SEK

Historical Annual Eps of Alzinova AB (publ) (2023 - 2012)

Year Eps Eps Growth
2023 -0.41 SEK 24.07%
2022 -0.54 SEK -25.58%
2021 -0.43 SEK -16.22%
2020 -0.37 SEK 33.93%
2019 -0.56 SEK -47.37%
2018 -0.38 SEK -65.22%
2017 -0.23 SEK 14.81%
2016 -0.27 SEK 49.06%
2015 -0.53 SEK -381.82%
2014 -0.11 SEK 52.17%
2013 -0.23 SEK 82.25%
2012 -1.30 SEK 0.0%

Peer Eps Comparison of Alzinova AB (publ)

Name Eps Eps Difference
Amniotics AB (publ) -0.01 SEK -3627.273%
Asarina Pharma AB (publ) -0.57 SEK 28.07%
BioArctic AB (publ) 2.60 SEK 115.769%
Calliditas Therapeutics AB (publ) -8.69 SEK 95.282%
Saniona AB (publ) -1.29 SEK 68.217%
Simris Alg AB (publ) -0.16 SEK -156.25%
Vicore Pharma Holding AB (publ) -3.22 SEK 87.267%
Scandinavian ChemoTech AB (publ) -1.13 SEK 63.717%
NextCell Pharma AB -1.03 SEK 60.194%
Elicera Therapeutics AB (publ) -0.83 SEK 50.602%
AcouSort AB (publ) -1.29 SEK 68.217%
Active Biotech AB (publ) -0.17 SEK -141.176%
Alligator Bioscience AB (publ) -0.55 SEK 25.455%
Camurus AB (publ) 7.78 SEK 105.27%
Cantargia AB (publ) -1.65 SEK 75.152%
Genovis AB (publ.) 0.94 SEK 143.617%
Guard Therapeutics International AB (publ) -11.26 SEK 96.359%
Mendus AB (publ) -4.40 SEK 90.682%
Kancera AB (publ) -0.80 SEK 48.75%
Karolinska Development AB (publ) 0.02 SEK 2150.0%
LIDDS AB (publ) -0.63 SEK 34.921%
Lipum AB (publ) -4.45 SEK 90.787%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -115.789%
Magle Chemoswed Holding AB (publ) 1.13 SEK 136.283%
Modus Therapeutics Holding AB (publ) -1.01 SEK 59.406%
OncoZenge AB (publ) -1.36 SEK 69.853%
Xbrane Biopharma AB (publ) -1.27 SEK 67.717%
Xintela AB (publ) -0.13 SEK -215.385%
Ziccum AB (publ) -1.54 SEK 73.377%
Isofol Medical AB (publ) -0.23 SEK -78.261%
Xspray Pharma AB (publ) -6.76 SEK 93.935%
CombiGene AB (publ) -1.80 SEK 77.222%
Diamyd Medical AB (publ) -1.60 SEK 74.375%
Intervacc AB (publ) -1.69 SEK 75.74%
Sprint Bioscience AB (publ) -0.01 SEK -6407.937%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -86.364%
Corline Biomedical AB -0.08 SEK -386.936%
IRLAB Therapeutics AB (publ) -3.43 SEK 88.047%
Bio-Works Technologies AB (publ) -1.57 SEK 73.885%
Aptahem AB (publ) -0.05 SEK -748.861%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 95.879%
Fluicell AB (publ) -0.24 SEK -70.833%
Biovica International AB (publ) -2.14 SEK 80.841%
Spago Nanomedical AB (publ) -0.43 SEK 4.651%
Abliva AB (publ) -0.09 SEK -353.54%
Egetis Therapeutics AB (publ) -1.27 SEK 67.717%
2cureX AB (publ) -1.85 SEK 77.838%
I-Tech AB 1.70 SEK 124.118%
Hansa Biopharma AB (publ) -15.83 SEK 97.41%
Cyxone AB (publ) -0.22 SEK -86.364%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 79.293%
Biosergen AB -0.60 SEK 31.667%
Nanologica AB (publ) -2.05 SEK 80.0%
SynAct Pharma AB -6.64 SEK 93.825%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -57.692%
BioInvent International AB (publ) -5.02 SEK 91.833%
Stayble Therapeutics AB (publ) -0.92 SEK 55.435%
Oncopeptides AB (publ) -1.96 SEK 79.082%
Pila Pharma AB (publ) -0.47 SEK 12.766%
Ascelia Pharma AB (publ) -3.24 SEK 87.346%
Diagonal Bio AB (publ) -0.32 SEK -28.125%